GLP Watchdog

Allara Health vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Allara Health has none. Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. Hers starts at $199 a month for compounded semaglutide injection.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Allara Health / Hers

Allara Health logo

Allara Health

6.5/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
Brand-name only; no compounding
Lowest standing price
$149/moMedication only; a membership is required on top
$199/moCompounded semaglutide injection
States
44 states
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked September 2026
Visit Allara Health
Visit Hers

Neither Allara Health nor Hers pays us. Links to them earn nothing. Scores: Allara Health 6.5, Hers 6.8. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Allara Health has none.

  2. 02

    Hers names three pharmacies. Allara Health sells brand-name medication only.

  3. 03

    Allara Health prices medication from $149 a month plus a required membership, so it has no all-in monthly price to set against another seller's. Hers starts at $199 a month for compounded semaglutide injection.

  4. 04

    Only Hers lists a price for compounded semaglutide injection and brand-name tirzepatide pen.

  5. 05

    Hers covers six states Allara Health does not.

  6. 06

    Allara Health does not state its cancellation terms; Hers states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Allara Health

Hers

Compounded semaglutide injection
Not sold or not priced

$199/mo

$2,388 a year

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Clinician visits, coaching
Medication
Billed separately
Medication
Clinician visits, coaching
Cancel any time
Not stated
Yes, stated
Minimum term
1 month
None
Refunds
Refund requests within 30 days of a charge; Allara Rx prescriptions are final sale
No refund guaranteed once the pharmacy has processed an order
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Allara Health: September 28, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Allara Health

6.5/10
  • No FDA warning letter on record
  • Publishes no GLP-1 price
Visit Allara Health

The case for Hers

6.8/10
  • Sells compounded semaglutide injection and brand-name tirzepatide pen, which Allara Health does not price
  • Lists 50 states against 44
  • States you can cancel at any time
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Allara Health 6.5 · Hers 6.8 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

9.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.0

Accessibility10%

9.0A
vs
B
10.0

Support10%

4.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Allara Health vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Allara Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Allara Health sells brand-name medication only.
Allara Health does not state its cancellation terms. Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Neither Allara Health nor Hers pays us. Links to them earn nothing. Scores: Allara Health 6.5, Hers 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks